Insider · CIK 0001314596
Keith Katkin
Files at EBS (Emergent BioSolutions Inc.), SNDX (Syndax Pharmaceuticals Inc), ELDN (Eledon Pharmaceuticals, Inc.). First filing May 19, 2025, latest May 28, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
EBS: Emergent BioSolutions Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
SNDX: Syndax Pharmaceuticals Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 2Weak | Emergent BioSolutions Inc. | $49k 7,844 shares | -8% | +50% from low-47% from high | |
| 60Notable | Syndax Pharmaceuticals Inc | $91k 10,000 shares | +11% | +4% from low-57% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2025 | EBS Emergent BioSolutions Inc. | SOpen-market sale Common Stock10b5-1 | -7,844 | $6.30 | $49k | 86,431 | May 28, 2025 |
| May 19, 2025 | SNDX Syndax Pharmaceuticals Inc | POpen-market purchase Common Stock | +10,000 | $9.11 | $91k | 100,000 | May 19, 2025 |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Common Stock | +34,403 | $0.00 | $0 | 94,275 | May 2, 2025 |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,824 | $0.00 | $0 | 41,572 | May 2, 2025 |
| Feb 5, 2025 | SNDX Syndax Pharmaceuticals Inc | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 90,000 | Feb 7, 2025 |
| Jan 10, 2025 | ELDN Eledon Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +77,175 | $0.00 | $0 | 77,175 | Jan 13, 2025 |
| Jan 10, 2025 | ELDN Eledon Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +8,575 | $0.00 | $0 | 8,575 | Jan 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.